Newron Pharmaceuticals SpA (XTER:NP5) Change In Receivables : €1.06 Mil (TTM As of Dec. 2023)

Newron Pharmaceuticals SpA Change In Receivables Chart

Newron Pharmaceuticals SpA Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Change In Receivables		Get a 7-Day Free Trial					-0.15	3.17	3.85	1.42	1.06

Newron Pharmaceuticals SpA Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial															1.97	0.75	0.67	-0.02	1.08

Newron Pharmaceuticals SpA Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Newron Pharmaceuticals SpA  (XTER:NP5) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Newron Pharmaceuticals SpA's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

2. In Ben Graham's calculation of liquidation value, Newron Pharmaceuticals SpA's accounts receivable are only considered to be worth 75% of book value:

Newron Pharmaceuticals SpA's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Newron Pharmaceuticals SpA Change In Receivables Related Terms

Thank you for viewing the detailed overview of Newron Pharmaceuticals SpA's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Newron Pharmaceuticals SpA (XTER:NP5) Business Description